According to a new report, published by KBV research, The Global Hemostats Market size is expected to reach $3.7 billion by 2028, rising at a market growth of 5.3% CAGR during the forecast period.
The General Surgery segment is expected to witness a CAGR of 6.1% during (2022 - 2028). Anatomy, physiology, metabolism, immunology, nutrition, pathology, wound healing, shock and resuscitation, intensive care, and neoplasia are all topics covered in general surgery, which is a branch of surgery with a basic body of knowledge shared by all surgical specialties. The fact that the general surgeries are most commonly conducted surgeries, it can be attributed that the hemostats market would grow in this segment.
The Matrix & Gel segment acquired maximum revenue share in the Global Hemostats Market by Formulation in 2021 thereby, achieving a market value of $1.2 billion by 2028. This is due to an increase in the number of cosmetic surgeries, a rise in the prevalence of cardiac disorders, and a growth the demand for hemostats to lessen surgical injuries. Gum retraction, preventing bleeding, and lowering irritation related to obtaining impressions for class V restorations can all handled with gel hemostats.
The Gelatin Based segment is showcasing CAGR of 6.3% during (2022 - 2028). The Gelatin-based hemostat devices, which function at the final stage of the coagulation system by promoting fibrin production, are mechanical hemostats made from gelatin produced from swine or bovine skin. They offer a mechanical matrix to which clots can cling and are readily reabsorbed in 4-6 weeks due to which the demand for gelatin-based hemostats devices is increasing.
The North America market dominated the Global Hemostats Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.3 billion by 2028. The Europe market is exhibiting a CAGR of 4.9% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 5.8% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/hemostats-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.
By Application
By Formulation
By Type
By Geography
Companies Profiled
Unique Offerings 
